BioMedPartners
82
21M
46
4.10
20
0.44
19
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Switzerland. The main office of represented VC is situated in the Basel.
The fund was created by Gerhard Ries. We also calculated 4 valuable employees in our database.
The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Anergis, Inotrem, Miracor Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Developer Platform, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. This BioMedPartners works on 0 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the BioMedPartners, startups are often financed by Novartis Venture Fund, High-Tech Gru00fcnderfonds, KfW. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, BB Biotech Ventures, Neomed Management. In the next rounds fund is usually obtained by SV Health Investors, Novartis Venture Fund, HBM Healthcare Investments AG.
Investments analytics
Analytics
- Total investments
- 82
- Lead investments
- 20
- Exits
- 19
- Rounds per year
- 4.10
- Follow on index
- 0.44
- Investments by industry
- Biotechnology (67)
- Health Care (55)
- Therapeutics (27)
- Medical Device (24)
- Medical (23) Show 23 more
- Investments by region
-
- Switzerland (43)
- Germany (23)
- Belgium (5)
- France (4)
- Austria (3) Show 2 more
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 47M
- Group Appearance index
- 0.99
- Avg. company exit year
- 9
- Avg. multiplicator
- 4.56
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Anergis | 04 Apr 2016 | Biotechnology, Health Care, Medical, Personal Health, Life Science | Late Stage Venture | 5M | Switzerland, Vaud |
| Evolva | 11 Dec 2009 | Biotechnology, Food and Beverage, Health Care, Wellness, Consulting | Early Stage Venture | 17M | Switzerland, Aargau |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.